Add BrightSurf on Google Email

Monash University


Study reveals how microbes help detoxify our atmosphere

Researchers at Monash University have discovered how microbes consume huge amounts of carbon monoxide and reduce its levels in the atmosphere. By using a special enzyme called CO dehydrogenase, microbes extract energy from CO, powering their own survival while also cleaning the air.

SourceMonash University·JournalNature Chemical Biology·TypeExperimental study·DateJan 29, 2025

Study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system

Researchers have identified a form of Vitamin B6 bound to MR1 as a means of engaging tumour-reactive immune cells, suggesting that altered cellular metabolism/metabolite levels may distinguish cancer cells. Understanding the breadth of MR1-mediated immunity could illuminate routes for therapeutic intervention with broad utility.

SourceMonash University·JournalProceedings of the National Academy of Sciences·DateNov 26, 2024

New hope for diabetic heart disease treatment

Researchers at Monash University have discovered that LXA4 can halve inflammation and scar formation in diabetic hearts, offering a promising new treatment option. The study's findings suggest that LXA4-based therapies could be used to manage diabetic heart disease more effectively.

SourceMonash University·JournalCardiovascular Diabetology·TypeExperimental study·DateNov 20, 2024

Adapting GenAI for the next generation of learning

A new study by Monash University researchers highlights essential factors for adapting Generative AI (GenAI) to support human learning in all levels of education and workplaces. The key considerations include understanding how to use GenAI to enhance human learning while fostering critical thinking and self-reflection skills.

SourceMonash University·JournalNature Human Behaviour·TypeCommentary/editorial·DateOct 22, 2024

New AI tool for rapid and cost-effective drug discovery

PSICHIC uses sequence data and AI to decode protein-molecule interactions with state-of-the-art accuracy, eliminating costly processes like 3D structures. The tool effectively screens new drug candidates and performs selectivity profiling, offering a more efficient and reliable approach to drug discovery.

SourceMonash University·JournalNature Machine Intelligence·TypeData/statistical analysis·DateJun 19, 2024

Immune key to chronic viral infections discovered

Australian researchers have identified a previously unknown immune B memory cell that fails to produce high levels of antibodies against persistent infections. The discovery may lead to earlier intervention and prevention of chronic viral infections like HIV or hepatitis.

SourceMonash University·JournalImmunity·TypeExperimental study·DateApr 8, 2024

Researchers discover key to epithelial cell growth

Australian researchers at Monash University have discovered a new way that epithelial cells form tissues of the right size and shape by adhering to each other through basal spot junctions. This finding is crucial for understanding human diseases, including cancers, where Hippo signalling plays a key role.

SourceMonash University·JournalDevelopmental Cell·TypeExperimental study·DateDec 21, 2023

Common drug can improve hand osteoarthritis symptoms: Study

A Monash University study found that methotrexate, a low-cost and effective treatment for inflammatory joint conditions, can reduce pain and stiffness in patients with symptomatic hand OA. The study's results suggest that methotrexate may be a viable treatment option for people with hand osteoarthritis and inflammation.

SourceMonash University·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateOct 12, 2023

The health impact of climate change is not adequately recorded: study

A Monash University-led study proposes standardizing medical terminology to capture climate-driven disaster events impacting human health. The research highlights the need for comprehensive clinical terminologies, particularly those linked to environmental factors, to improve disaster preparedness and response efforts.

SourceMonash University·JournalJournal of the American Medical Informatics Association·TypeData/statistical analysis·DateAug 10, 2023

New research shows AI can ask another AI for a second opinion on medical scans

Researchers at Monash University developed a co-training AI algorithm that can effectively mimic human oversight in medical imaging. The algorithm achieved an average improvement of 3% compared to state-of-the-art approaches using limited annotated data, enabling AI models to make more informed decisions and uncover accurate diagnoses.

SourceMonash University·JournalNature Machine Intelligence·TypeImaging analysis·DateJul 25, 2023

International migrants left behind in HIV response: study

A recent study found that international migrants in Australia are at increased risk of HIV infection due to reduced access to PrEP, a highly effective prevention measure. The study identified multiple barriers, including lack of awareness, low risk perception, and provider discrimination, which hinder their ability to access PrEP.

SourceMonash University·JournalThe Lancet Public Health·TypeSystematic review·DateJul 5, 2023

World's biggest study of wildfire smoke impact reveals alarming long-term health impacts

A comprehensive study found that increased exposure to wildfire-related PM2.5 was associated with a higher risk of all-cause and nonaccidental mortality, as well as an increased risk of dying from neoplasms. The research used a large-scale national cohort database from the UK Biobank, involving 492,394 participants.

SourceMonash University·JournalJournal of Hazardous Materials·TypeMeta-analysis·DateJun 21, 2023

Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of an open-label, cluster randomised (COBIN) trial

A 12-month lifestyle intervention led by community health workers reduced systolic blood pressure in Nepal. However, a 5-year follow-up found that the benefit was not maintained, with blood pressure rising again after the intervention ended. This highlights the need for ongoing education and follow-up to prevent potential harm.

SourceMonash University·JournalThe Lancet Global Health·TypeRandomized controlled/clinical trial·DateJun 20, 2023